With respect to the available findings, GPR75 is a prominent player in the control of metabolism and glucose homeostasis, and may also be a novel therapeutic target to combat metabolic disorders caused by obesity. This evidence concerns the gene GPR75 and obesity due to melanocortin 4 receptor deficiency.